The capsule of Mycobacterium tuberculosis and its implications for pathogenicity

Tubercle and Lung Disease

Volumn 79, Issue 3, 1999, Pages 153-169

  Daffe M ^a   Etienne, G ^a  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; DETERGENT; GLYCAN; LIPID; PEROXIDASE; POLYSACCHARIDE; PROTEIN; PROTEINASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL LIPASE;

BACTERIAL MEMBRANE; BACTERIUM ADHERENCE; BACTERIUM CULTURE; CAUSE OF DEATH; CELL MEMBRANE; DIFFUSION; HOST CELL; LYMPHOCYTE PROLIFERATION; MACROMOLECULE; MACROPHAGE; MICROSCOPY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; REVIEW; TUBERCULOSIS;

EID: 0037741082     PISSN: 09628479     EISSN: None     Source Type: Journal    
DOI: 10.1054/tuld.1998.0200     Document Type: Article

References (173)

1. Moran N. WHO issues another gloomy tuberculosis report. Nature Medicine. 2:1996;377.
2. Daffé M, Draper P. The envelope layers of mycobacteria with reference to their pathogenicity. Adv Microbial Phys. 39:1998;131-203.
3. Roberts I S. The biochemistry and genetics of capsular polysaccharide production in bacteria. Annu Rev Microbiol. 50:1996;285-315.
4. Ortalo-Magné A, Lemassu A, Lanéelle M-A. Identification of the surface-exposed lipids on the cell envelopes of Mycobacterium tuberculosis and other mycobacterial species. J Bacteriol. 178:1996;456-461.
5. Chapman G B, Hanks J H, Wallace J H. An electron microscope study of the disposition and fine structure of Mycobacterium lepraemurium in mouse spleen. J Bacteriol. 77:1959;205-211.
6. Hanks J H. The problem of preserving internal structures in pathogenic mycobacteria by conventional methods of fixation. Int J Leprosy. 29:1961;175-178.
7. Hanks J H. Demonstration of capsules on M.leprae during carbol-fuchsin staining mechanism of the Ziehl-Neelsen stain. Int J Leprosy. 26:1961;179-182.
8. Hanks J H, Moore J T, Michaels J E. Significance of capsular components of Mycobacterium leprae and other mycobacteria. Int J Leprosy. 26:1961;74-83.
9. Hanks J H. The origin of the capsules on Mycobacterium leprae and other tissue-grown mycobacteria. Int J Leprosy. 26:1961;172-174.
10. Hanks J H. Capsules in electron micrographs of Mycobacterium leprae. Int J Leprosy. 29:1961;84-87.
11. Hart P D, Armstrong J A, Brown C A, Draper P. Ultrastructural study of the behavior of macrophages toward parasitic mycobacteria. Infect Immun. 5:1972;803-807.
12. Ryter A, Fréhel C, Rastogi N, David H L. Macrophage interaction with mycobacteria including M. leprae. Acta Leprologica. 2:1984;211-226.
13. Fréhel C, Ryter A, Rastogi N, David H L. The electron-transparent zone in phagocytized Mycobacterium avium and other mycobacteria: formation, persistence and role in bacterial survival. Ann Inst Pasteur-Microbiol. 137B:1986;239-257.
14. Rastogi N, David H L. Mechanisms of pathogenicity in mycobacteria. Biochimie. 70:1988;1101-1120.
15. De Chastellier C, Lang T, Thilo L. Phagocytic processing of the macrophage endoparasite, Mycobacterium avium, in comparison to phagosomes which contain Bacillus subtilis or latex beads. Eur J Cell Biol. 68:1995;167-182.
16. Fréhel C, Rastogi N, Bénichou J-C, Ryter A. Do test tube-grown pathogenic mycobacteria possess a protective capsule. FEMS Microbiol Lett. 56:1988;225-230.
17. Paul T R, Beveridge T J. Reevaluation of envelope profiles and cytoplasmic ultrastructure of mycobacteria processed by conventional embedding and freeze-substitution protocols. J Bacteriol. 174:1992;6508-6517.
18. Paul T R, Beveridge T J. Preservation of surface lipids and determination of ultrastructure of Mycobacterium kansasii by freeze-substitution. Infect Immun. 62:1994;1542-1550.
19. Ortalo-Magné A, Dupont M-A, Lemassu A, Andersen A B, Gounon P, Daffé M. Molecular composition of the outermost capsular material of the tubercle bacillus. Microbiology. 141:1995;1609-1620.
20. Wiker H G, Harboe M. The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol Rev. 56:1992;648-661.
21. Draper P, Rees R J W. The nature of the electron-transparent zone that surrounds Mycobacterium leprae murium. J Gen Microbiol. 77:1973;79-87.
22. Hunter S W, Fujiwara T, Brennan P J. Structure and antigenicity of the major specific glycolipid antigen of Mycobacterium leprae. J Biol Chem. 257:1982;15072-15078.
23. Rastogi N, Lévy-Frebault V, Blom-Potar M-C, David H L. Ability of smooth and rough variants of Mycobacterium avium and M. intracellulare to multiply and survive intracellularly: role of C-mycosides. Zbl Bakt Hyg. 270:1989;345-360.
24. Daffé M, Lanéelle M-A, Puzo G. Structural elucidation by field desorption and electron-impact mass spectrometry of the C- mycosides isolated fromMycobacterium smegmatis. Biochim Biophys Acta. 751:1983;439-443.
25. Draper P, Rees R J W. Electron transparent zone of mycobacteria may be a defence mechanism. Nature. 228:1970;860-861.
26. Rastogi N, Fréhel C, David H L. Triple-layered structure of mycobacterial cell wall: evidence for the exixtence of a polysaccharide-rich outer layer in 18 mycobacterial species. Curr Microbiol. 13:1986;237-242.
27. Rastogi N, Fréhel C, Ryter A, David H L. Comparative ultrastructure of Mycobacterium leprae and M. avium grown in experimental hosts. Ann Microbiol (Inst. Pasteur). 133B:1982;109-128.
28. Lemassu A, Ortalo-Magné A, Bardou F, Silve G, Lanéelle M-A, Daffé M. Extracellular and surface-exposed polysaccharides of non-tuberculous mycobacteria. Microbiology. 142:1996;1513-1520.
29. Raynaud C, Etienne G, Peyron P, Lanéelle M-A, Daffé M. Extracellular enzyme activities potentially involved in the pathogenicity of Mycobacterium tuberculosis. Microbiology. 144:1998;577-587.
30. Middlebrook G, Dubos R J, Pierce C. Virulence and morphological characteristics of mammalian tubercle bacilli. J Exp Med. 86:1947;175-184.
31. Bloch H, Noll H. Studies on the virulence of tubercle bacilli. Variations in virulence effected by Tween 80 and thiosemicarbazone. J Exp Med. 97:1953;1-16.
32. Espitia C, Elinos M, Hernandez-Pando R, Mancilla R. Phosphate starvation enhances expression of the immunodominant 38-kilodalton protein antigen of Mycobacterium tuberculosis: demonstration by immunogold electron microscopy. Infect Immun. 60:1992;998-3001.
33. Rambukkana A, Das P K A, Chand A, Baas J G, Groothuis D G, Kolk A H J. Subcellular distribution of monoclonal antibody defined epitopes on immunodominant Mycobacterium tuberculosis proteins in the 30-kDa region: identification and localization of 29-s33-kDa doublet proteins on mycobacterial cell wall. Scand J mmunol. 33:1991;763-775.
34. Harth G, Lee B-Y, Wang J, Clemens D L, Horwitz M A. Novel insights into the genetics, biochemistry and immunocytochemistry of the 30-kilodalton major extracellular protein of Mycobacterium tuberculosis. Infect Immun. 64:1996;3038-3047.
35. Menozzi F D, Rouse J H, Alavi M. Identification of a heparin-binding hemagglutinin present in Mycobacteria. J Exp Med. 184:1996;993-1001.
36. Cunningham A F, Spreadbury C L. Mycobacterial stationary phase induced by low oxygen tension: cell wall thickening and localization of the 16-kilodalton α-crystallin homolog. J Bacteriol. 180:1998;801-808.
37. Ozanne V, Ortalo-Magné A, Vercellone A, Fournié J-J, Daffé M. Cytometric detection of mycobacterial surface antigens: exposure of mannosyl epitopes and of arabinan segment of arabinomannans. J Bacteriol. 178:1996;7254-7259.
38. Harboe M, Wiker H G, Ulvund G. MPB70 and MPB83 as indicators of protein localization in mycobacterial cells. Infect Immun. 66:1998;289-296.
39. Lefèvre P, Braibant M, de Wit L. Three different putative phosphate transport receptors are encoded by the Mycobacterium tuberculosis genome and are present at the surface of Mycobacterium bovis BCG. J Bacteriol. 179:1997;2900-2906.
40. Cywes C, Hoppe H C, Daffé M, Ehlers M R W. Nonopsonic binding of Mycobacterium tuberculosis to complement receptor type 3 is mediated by capsular polysaccharides and is strain dependent. Infect Immun. 65:1997;4258-4266.
41. Lemassu A, Daffé M. Structural features of the exocellular polysaccharides of Mycobacterium tuberculosis. Biochem J. 297:1994;351-357.
42. Antoine A D, Tepper B S. Characterization of glycogen from mycobacteria. Arch Biochem Biophys. 134:1969;207-213.
43. Chatterjee D, Lowell K, Rivoire B, McNeil M R, Brennan P J. Lipoarabinomannan of Mycobactererium tuberculosis. Capping with mannosyl residues in some strains. J Biol Chem. 267:1992;6234-6239.
44. 13C-NMR analyses. J Biol Chem. 265:1990;6734-6743.
45. Ortalo-Magné A, Andersen A B, Daffé M. The outermost capsular arabinomannans and other mannoconjugates of virulent and avirulent tubercle bacilli. Microbiology. 142:1996;927-935.
46. Abou-Zeid C, Smith I, Grange J M, Ratliff T L, Steele J, Rook G A W. The secreted antigens of Mycobacterium tuberculosis and their relationship to those recognized by the available antibodies. J Gen Microbiol. 134:1988;531-538.
47. Andersen P, Askgaard D, Ljungqvist L, Bennedsen J, Heron I. Proteins released from Mycobacterium tuberculosis during growth. Infect Immun. 59:1991;1905-1910.
48. Wiker H G, Harboe M, Nagai S. A localization index for distinction between extracellular and intracellular antigens of Mycobacterium tuberculosis. J Gen Microbiol. 137:1991;875-884.
49. Sonnenberg M G, Belisle J T. Definition of Mycobacterium tuberculosis culture filtrate proteins by two-dimentional polyacrylamide gel electrophoresis, N-terminal amino-acid sequencing and electrospray mass spectrometry. Infect Immun. 65:1997;4515-4524.
50. Timm J, Perilli M G, Duez C. Transcription and expression analysis, using lacZ and phoA gene fusions, of Mycobacterium fortuitumβ-lactamase genes cloned from a natural isolate and a high-level β-lactamase producer. Mol Microbiol. 12:1994;491-504.
51. Berthet F-X, Rauzier J, Lim E M, Philipp W, Gicquel B, Portnoï D. Characterization of the Mycobacterium tuberculosis erp gene encoding a potential cell surface protein with repetitive structures. Microbiology. 141:1995;2123-2130.
52. Jackson M, Portno. D, Catheline D. Mycobacterium tuberculosis Des protein: an immunodominant target for the humoral response of tuberculosis patients. Infect Immun. 65:1997;2883-2889.
53. Chubb A J, Woodman Z L, da Silva Tatley F M P R, Hoffmann H J, Scholle R R, Ehlers M R W. Identification of Mycobacterium tuberculosis signal sequences that direct the export of a leaderless b-lactamase gene product in Escherichia coli. Microbiology. 144:1998;1619-1629.
54. Morosoli R, Schareck F, Kluepfel D. Protein secretion in streptomycetes. FEMS Microbiol (lett). 146:1997;167-174.
55. Cole S T, Brosch R, Parkhill J. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 393:1998;537-544.
56. Zhang Y, Lathigra R, Garbe T, Catty D, Young D. Genetic analysis of superoxide dismutase, the 23-kilodalton antigen of Mycobacterium tuberculosis. Mol Microbiol. 5:1991;381-391.
57. Andersen A B, Andersen P, Ljungqvist L. Structure and function of a 40 000-molecular weight protein antigen of Mycobacterium tuberculosis. Infect Immun. 60:1992;2317-2323.
58. Harth G, Clemens D L, Horwitz M A. Glutamine synthetase of Mycobacterium tuberculosis: extracellular release and characterization of its enzymatic activity. Proc Natl Acad Sci USA. 91:1994;9342-9346.
59. Harth G, Horwitz M A. Expression and efficient export of enzymatically active Mycobacterium tuberculosis glutamine synthetase inMycobacterium smegmatis and evidence that the information for export is contained within the protein. J Biol Chem. 272:1997;22728-22735.
60. Stelandre M, Bosseloir Y, De Bruyn J, Maes P, Content J. Cloning and sequence analysis of the gene encoding an NADP-dependant alcohol dehydrogenase in Mycobacterium bovis BCG. Gene. 121:1992;79-86.
61. Nagai S, Wiker H G, Harboe M, Kinomoto M. Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis. Infect Immun. 59:1991;372-382.
62. Wieles B, Nagai S, Wiker H G, Harboe M, Ottenhoff T H M. Identification and functional characterization of thioredoxin of Mycobacterium tuberculosis. Infect Immun. 63:1995;4946-4948.
63. Voladri R K R, Lakey D L, Hennigan S H, Menzies B E, Edwards K M, Kernodle D S. Recombinant expression and characterization of the major β-lactamase of Mycobacterium tuberculosis. Antimicrob Agents Chemother. 42:1998;1375-1381.
64. Laqueyrerie A, Militzer P, Romain F, Eiglmeier K, Cole S, Marchal G. Cloning, sequencing and expression of the apa gene coding for the Mycobacterium tuberculosis 45/47-kilodalton secreted antigen complex. Infect Immun. 63:1995;4003-4010.
65. Dobos K M, Swiderek K, Khoo K-H, Brennan P J, Belisle J T. Evidence for glycosylation sites on the 45-kilodalton glycoprotein of Mycobacterium tuberculosis. Infect Immun. 63:1995;2846-2853.
66. Espitia C, Espinosa R, Saavedra R. Antigenic and structural similarities between Mycobacterium tuberculosis 50- to 55-kilodalton andMycobacterium bovis BCG 45- to 47-kilodalton antigens. Infect Immun. 63:1995;580-884.
67. Manca C, Lyashchenko K, Colangeli R, Gennaro M L. MTC28, a novel 28-kilodalton proline-rich secreted antigen specific for the Mycobacterium tuberculosis complex. Infect Immun. 65:1997;4951-4957.
68. Harth G, Lee B-Y, Horwitz M A. High-level heterologous expression and secretion in rapidly growing nonpathogenic mycobacteria of four majorMycobacterium tuberculosis extracellular proteins considered to be leading vaccine candidates and drug targets. Infect Immun. 65:1997;2321-2328.
69. Harboe M, Oettinger T, Wiker H G, Rosenkrands I, Andersen P. Evidence for occurence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect Immun. 64:1996;16-22.
70. Belisle J T, Vissa V D, Sievert T, Takayama K, Brennan P J, Besra G S. Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science. 276:1997;1420-1422.
71. Borremans M, De Wit L, Volckaert G. Cloning, sequence determination and expression of a 32-kilodalton-protein gene of Mycobacterium tuberculosis. Infect Immun. 57:1989;3123-3130.
72. De Wit L, Palou M, Content J. Nucleotide sequence of the 85B-protein gene of Mycobacterium bovis BCG and Mycobacterium tuberculosis. DNA Seq. 4:1994;267-270.
73. Content J, de la Cuvellerie A, De Wit L, Vincent-Levy-Frébault V, Ooms J, De Bruyn J. The genes coding for the antigen 85 complexes of Mycobacterium tuberculosis and Mycobacterium bovis BCG are members of a gene family: cloning, sequence determination and genomic organization of the gene coding for antigen 85-C oftuberculosis. Infect Immun. 59:1991;3205-3212.
74. Leao S C, Rocha C L, Murillo L A, Parra C A, Patarroyo M E. A species-specific nucleotide sequence of Mycobacterium tuberculosis encodes a protein that exhibits hemolytic activity when expressed in Escherichia coli. Infect Immun. 63:1995;4301-4306.
75. Johansen K A, Gill R E, Vasil M L. Biochemical and molecular analysis of phospholipase C and phospholipase D activity in mycobacteria. Infect Immun. 64:1996;3259-3266.
76. Andersen A B, Hansen E B. Structure and mapping of antigenic domains of protein antigen b, a 38,000-molecular-weight protein of Mycobacterium tuberculosis. Infect Immun. 57:1989;2481-2488.
77. Zhang Y, Heym B, Allen B, Young D, Cole S. The catalase-peroxydase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature. 358:1992;591-593.
78. Li Z, Kelley C, Collins F, Rouse D, Morris S. Expression of katG in Mycobacterium tuberculosis is associated with its growth and persistence in mice and guinea pigs. J Infect Dis. 177:1998;1030-1035.
79. Rosenkrands I, Rasmussen P B, Carnio M, Jacobsen S, Theisen M, Andersen P. Identification and characterization of a 29-kilodalton protein from Mycobacterium tuberculosis culture filtrate recognized by mouse memory effector cells. Infect Immun. 66:1998;2728-2735.
80. Sorensen A L, Nagai S, Houen G, Andersen P, Andersen A B. Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect Immun. 63:1995;1710-1717.
81. Deshpande R G, Khan M B, Bhat D A, Navalkar R G. Isolation of a contact-dependant haemolysin from Mycobacterium tuberculosis. J Med Microbiol. 46:1997;233-238.
82. Wren B W, Stabler R A, Das S S. Characterization of a haemolysin from Mycobacterium tuberculosis with homology to a virulence factor ofSerpulina hyodysenteriae. Microbiology. 144:1998;1205-1211.
83. Verbon A, Hartskeerl R A, Schuitema A, Kolk A H J, Young D B, Lathigra R. The 14 000-molecular-weight antigen of Mycobacterium tuberculosis is related to the alpha-crystallin family of low-molecular-weight heat shock proteins. J Bacteriol. 174:1992;1352-1359.
84. Lee B-Y, Hefta S A, Brennan P J. Characterization of the major membrane protein of virulent Mycobacterium tuberculosis. Infect Immun. 60:1992;2066-2074.
85. Scorpio A, Zhang Y. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nature Med. 2:1996;662-667.
86. Escuyer V, Haddad N, Frehel C, Berche P. Molecular characterization of a surface-exposed superoxide dismutase of Mycobacterium avium. Microb Pathog. 20:1996;41-55.
87. Muno D, Isobe T, Okuyama T. The N-terminal sequences of superoxide dismutase from four mycobacterial species. Biochem Int. 2:1981;33-42.
88. Daffé M, Lacave C, Lanéelle M-A, Lanéelle G. Structure of the major triglycosyl phenol-phthiocerol of Mycobacterium tuberculosis (strain Canetti). Eur J Biochem. 167:1987;155-160.
89. Watanabe M, Yamada Y, Iguchi K, Minnikin D E. Structural elucidation of new phenolic glycolipids from Mycobacterium tuberculosis. Biochim Biophys Acta. 1210:1994;174-180.
90. Daffé M, McNeil M, Brennan P J. Novel type-specific lipooligosaccharides from Mycobacterium tuberculosis. Biochemistry. 30:1991;378-388.
91. Smith H. The biochemical challenge of microbial pathogenicity. J Appl Bact. 47:1984;395-404.
92. Dubos R J, Middlebrook G. Cytochemical reaction of virulent tubercle bacilli. Am Rev Tuberc. 58:1948;698-699.
93. Fenton M J, Vermeulen M W. Immunopathology of tuberculosis: roles of macrophages and monocytes. Infect Immun. 64:1996;683-690.
94. Bermudez L E, Goodman J. Mycobacterium tuberculosis invades and replicates within type II alveolar cells. Infect Immun. 64:1996;1400-1406.
95. Shepard C C. Growth characteristics of tubercle bacilli and certain other mycobacteria in Hela cells. J Exp Med. 105:1957;39-55.
96. McDonough K A, Kress Y. Cytotoxicity for lung epithelial cells is a virulence-associated phenotype of Mycobacterium tuberculosis. Infect Immun. 63:1995;4802-4811.
97. Hoppe H, Barend C, de Wet J M, Cywes C C, Daffé M, Ehlers M R W. Identification of phosphatidylinositol mannoside as a mycobacterial adhesin mediating both direct and opsonic binding to nonphagocytic mammalian cells. Infect Immun. 65:1997;3896-3905.
98. Ernst J D. Macrophage receptors for Mycobacterium tuberculosis. Infect Immun. 66:1998;1277-1281.
99. Ehlers M, Daffé M. Interactions between Mycobacterium tuberculosis and host cells: are mycobacterial sugars the key. Trends Microbiol. 6:1998;328-335.
100. Armstrong J A, Hart P D. Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. J Exp Med. 142:1975;1-15.
101. Cywes C, Godenir N L, Hoppe H C. Nonopsonic binding of Mycobacterium tuberculosis to human complement receptor type 3 expressed in Chinese hamster ovary cells. Infect Immun. 64:1996;5373-5383.
102. Hetland G, Wiker H G. Antigen 85C on Mycobacterium bovis BCG and M. tuberculosis promotes monocyte-CR3-mediated uptake of microbeads coated with mycobacterial products. Immunology. 82:1994;445-449.
103. Schlesinger L S. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J Immunol. 150:1993;2920-2930.
104. Schlesinger L S, Hull S R, Kaufman T M. Binding of terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages. J Immunol. 152:1994;4070-4079.
105. Schlesinger L S, Kaufman T M, Lyer S, Hull S R, Marchiando L K. Differences in mannose receptor-mediated uptake of lipoarabinomannan from virulent and attenuated strains ofMycobacterium tuberculosis by human macrophages. J Immunol. 157:1996;4568-4575.
106. Hunter S W, Brennan P J. Evidence for the presence of a phosphatidylinositol anchor on the lipoarabinomannan and lipomannan of Mycobacterium tuberculosis. J Biol Chem. 265:1990;9272-9279.
107. Herrmann J-L, O'Gaora P, Gallagher A, Thole J E R, Young D B. Bacterial glycoproteins: a link between glycosylation and proteolytic cleavage of a 19 kDa antigen fromMycobacterium tuberculosis. EMBO J. 15:1996;3547-3554.
108. Zaffran Y, Zhang L, Ellner J J. Role of CR4 in Mycobacterium tuberculosis -human macrophages binding and signal transduction in the absence of serum. Infect Immun. 66:1998;4541-4544.
109. Zimmerli S, Edwards S, Ernst J D. Selective receptor blockade during phagocytosis does not alter the survival and growth of Mycobacterium tuberculosis in human macrophages. Amer J Respir Cell Mol Biol. 15:1996;760-770.
110. Peterson P K, Gekker G, Hu S. CD14 receptor-mediated uptake of nonopsonized Mycobacterium tuberculosis by human microglia. Infect Immun. 63:1995;1598-1602.
111. Pugin J, Heumann I D, Tomasz A. CD14 is a pattern recognition receptor. Immunity. 6:1994;187-197.
112. Schorey J S, Carroll M C, Brown E J. A macrophage invasion mechanism of pathogenic mycobacteria. Science. 277:1997;1091-1093.
113. Downing J F, Pasula R, Wright J R, Twigg H L III, Martin W J II. Surfactant protein A promotes attachment of Mycobacterium tuberculosis to alveolar macrophages during infection with human immunodeficiency virus. Proc Natl Acad Sci USA. 92:1995;4848-4852.
114. Pasula R, Downing J F, Wright J R, Kachel D L, Davies T E Jr, Martin W J N. Surfactant protein A (SP-A) mediates attachment of Mycobacterium tuberculosis to murine alveolar macrophages. Am J Respir Cell Mol Biol. 17:1997;209-217.
115. Barclay R, Wheeler P R. Metabolism of mycobacteria in tissues. Ratledge C, Stanford J, Grange J M. Biology of mycobacteria. 1989;37-106 Academic Press, London.
116. Clemens D L, Lee B-Y, Horwitz M A. Purification, characterization and genetic analysis of Mycobacterium tuberculosis urease, a potentially critical determinant of host-pathogen interaction. J Bacteriol. 177:1995;5644-5652.
117. Kannan K B, Katoch V M, Sharma V D, Bharadwaj V P. Extracellular enzymes of mycobacteria. FEMS Microbiol (lett). 48:1987;31-33.
118. Rowland S S, Ruckert J L, Burall B N Jr. Identification of an elastolytic protease in stationary phase culture filtrates of Mycobacterium tuberculosis. FEMS Microbiol (lett). 151:1997;59-64.
119. Bermudez L E, Petrofsky M, Shelton K. Epidermal growth factor-binding protein in Mycobacterium avium and Mycobacterium tuberculosis: a possible role in the mechanism of infection. Infect Immun. 64:1996;2917-2922.
120. King C H, Mundayoor S, Crawford J T, Shinnick T M. Expression of contact-dependent cytolytic activity by Mycobacterium tuberculosis and isolation of the genomic locus that encodes the activity. Infect Immun. 61:1993;2708-2712.
121. Brzychcy M, Andrzejczyk Z, Zalewska N, Zwolska Z, Rudnicka W. Haemolytic activity of Mycobacterium spp. Acta Microbiol Pol. 46:1997;377-385.
122. Wheeler P R, Ratledge C. Metabolism of Mycobacterium tuberculosis. Bloom B R. Tuberculosis: pathogenesis, protection and control. 1994;353-385 ASM Press, Washington.
123. Gobin J, Horwitz M A. Exochelins of Mycobacterium tuberculosis remove iron from human iron-binding proteins and donate iron to mycobactins in the M. tuberculosis cell wall. J Exp Med. 183:1996;1527-1532.
124. Hall R M, Sritharan M, Messenger A J M, Ratledge C. Iron transport in Mycobacterium smegmatis: occurrence of iron-regulated envelope proteins as potential receptors for iron uptake. J Gen Microbiol. 133:1987;2107-2114.
125. Dover L G, Ratledge C. Identification of a 29 kDa protein in the envelope of Mycobacterium smegmatis as a putative ferri-exochelin receptor. Microbiology. 142:1996;1521-1530.
126. Raghu B, Raghupati S G. Isolation and characterization of siderophores and envelope proteins from mycobacteria. Biochem Mol Biol Int. 31:1993;333-339.
127. Chang Z, Choudhary A, Lathigra R, Quiocho F A. The immunodominant 38-kDa lipoprotein antigen of Mycobacterium tuberculosis is a phosphate-binding protein. J Biol Chem. 269:1994;1956-1958.
128. Braibant M, Lefèvre P, De Wit L. A Mycobacterium tuberculosis gene cluster encoding proteins of a phosphate transporter homologous to the Escherichia coli Pst system. Gene. 176:1996;171-176.
129. Braibant M, De Wit L, Peirs P. Structure of the Mycobacterium tuberculosis antigen 88, a protein related to the Escherichia coli PstA periplasmic phosphate permease subunit. Infect Immun. 62:1994;849-854.
130. Peirs P, de Wit L, Braibant M, Huygen K, Content J. A serine/threonine protein kinase from Mycobacterium tuberculosis. Eur J Biochem. 244:1997;604-612.
131. Hirsch D, Stahl A, Lodish H F. A family of fatty acid transporters conserved from mycobacterium to man. Proc Natl Acad Sci USA. 95:1998;8625-8629.
132. Fréhel C, Rastogi N. Mycobacterium leprae surface components intervene in the early phagosome-lysosome fusion inhibition event. Infect Immun. 55:1987;2916-2921.
133. Crowle A J, Dahl R, Ross E, May M H. Evidence that vesicules containing living, virulent Mycobacterium tuberculosis or Mycobacterium avium in cultured human macrophages are not acidic. Infect Immun. 59:1991;1823-1831.
134. Clemens D L, Horwitz M A. Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. J Exp Med. 181:1995;257-270.
135. Sturgill-Koszycki S, Schlesinger P H, Chakraborty P. Lack of acidification in Mycobacterium produced by exclusion of the vesicular proton-ATPase. Science. 263:1994;678-681.
136. De Chastellier C, Thilo L. Phagosome maturation and fusion with lysosomes in relation to surface property and size of phagocytic particle. Eur J Cell Biol. 74:1997;49-62.
137. Baorto D M, Gao Z, Malaviya R. Survival of FimH-expressing enterobacteria in macrophages relies on glycolip traffic. Nature. 389:1997;636-639.
138. Middlebrook G, Cohn M L. Some observations on the pathogenicity of isoniazid-resistant variants of tubercle bacilli. Science. 118:1953;297-299.
139. Wilson T M, de Lisle G W, Collins D M. Effect of inhA and katG on isoniazid resistance and virulence of Mycobacterium bovis. Mol Microbiol. 15:1995;1009-1015.
140. Mayer B K, Falkinham J O III. Superoxide dismutase activity of Mycobacterium avium, M. intracellulare and M. scrofulaceum. Infect Immun. 53:1986;631-635.
141. Beaman B L, Scates S M, Moring S E, Deem R, Misra H P. Purification and properties of a unique superoxide dismutase from Nocardia asteroides. J Biol Chem. 258:1983;91-96.
142. Beaman L, Beaman B L. Monoclonal antibodies demonstrate that superoxide dismutase contributes to protection of Nocardia asteroides within the intact host. Infect Immun. 58:1990;3122-3128.
143. De Groote M A, Ochsner U A, Shiloh M U. Periplasmic superoxide dismutase protects Salmonella from products of phagocyte NADPH-oxidase and nitric oxide synthase. Proc Natl Acad Sci USA. 94:1997;13997-14001.
144. San Mateo L R, Hobbs M M, Kawula T H. Periplasmic copper-zinc superoxide dismutase protects Haemophilus ducreyi from exogenous superoxide. Mol Microbiol. 27:1998;391-404.
145. Holmgren A. Thioredoxin. Annu Rev Biochem. 54:1985;237-271.
146. Wieles B, van Noort J, Drijfhout J W, Offringa R, Holmgren A, Ottenhoff T M. Purification and functional analysis of the Mycobacterium leprae thioredoxin/thioredoxin reductase hybrid protein. J Biol Chem. 270:1995;25604-25606.
147. Wieles B, Ottenhoff T M, Steenwijk T M, Franken K L M C, de Vries R R P, Langermans J A M. Increased intracellular survival of Mycobacterium smegmatis containing the Mycobacterium leprae thioredoxin/thioredoxin reductase gene. Infect Immun. 65:1997;2537-2541.
148. Moskovitz J, Rahman M A, Strassman J. Escherichia coli peptide methionine sulfoxide reductase gene: regulation of expression and role in protecting against oxidative damage. J Bacteriol. 177:1995;502-507.
149. Pabst M, Gross J M, Brozna J P, Goren M B. Inhibition of macrophage priming by sulfatide from Mycobacterium tuberculosis. J Immunol. 140:1988;634-640.
150. Brozna J P, Horan M, Rademacher J M, Pabst K M, Pabst M J. Monocyte responses to sulfatide from Mycobacterium tuberculosis: inhibition of priming for enhanced release of superoxide, associated with increase secretion of interleukin-1 and tumor necrosis factor alpha, and altered protein phosphorylation. Infect mmun. 59:1991;2542-2548.
151. Wayne L G. Cultivation of Mycobacterium tuberculosis for research purposes. Bloom B R. Tuberculosis: pathogenesis, prevention, and control. 1994;73-83 ASM Press, Washington.
152. Yuan Y, Crane D D, Barry III C E. Stationary phase-associated protein expression in Mycobacterium tuberculosis: function of the mycobacterial α-crystallin homolog. J Bacteriol. 178:1996;4484-4492.
153. Yuan Y, Crane D D, Simpson R M. The 16 kDa α-cristallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages. Proc Natl Acad Sci. 95:1998;9578-9583.
154. Connell N D, Nikaido H. Membrane permeability and transport in Mycobacterium tuberculosis. Bloom B R. Tuberculosis: pathogenesis, prevention, and control. 1994;333-352 ASM Press, Washington.
155. Wagner B, Fattorini L, Wagner M. Antigenic properties and immunoelectron microscopic localization of Mycobacterium fortuitumβ-lactamase. Antimicrob Agents Chemother. 39:1995;739-745.
156. Bloch H. Studies on the virulence of tubercle bacilli. Isolation and biological properties of a constituent of virulent organisms. J Exp Med. 91:1950;197-218.
157. Goren M B. Mycobacterial fatty acid esters of sugars and sulfosugars. Hand Book. Lip Res. 6:1990;363-461.
158. Vergne I, Daffé M. Interaction of mycobacterial glycolipids with host cells. Frontiers Biosci. 3:1998;865-876.
159. Goren M B. Sulfolipid I of Mycobacterium tuberculosis, strain H37Rv. I. Purification and properties. Biochim Biophys Acta. 210:1970;116-126.
160. Saito R, Tanaka A, Sugiyama K. Adjuvant effect of cord factor, a mycobacterial lipid. Infect Immun. 13:1976;776-781.
161. Prasad H K, Mishra R S, Nath I. Phenolic glycolipid-I of Mycobacterium leprae induces general suppression of in vitro concanavalin A responses unrelated to leprosy type. J Exp Med. 165:1987;239-244.
162. Fournié J-J, Adams E, Mullins R J, Basten A. Inhibition of human lymphoproliferative response by mycobacterial phenolic glycolipids. Infect Immun. 57:1989;3653-3659.
163. Ellner J J, Daniel T M. Immunosuppression by mycobacterial arabinomannan. Clin Exp Immunol. 35:1979;250-257.
164. Moreno C, Mehlert A, Lamb J. The inhibitory effects of mycobacterial lipoarabinomannan and polysaccharides upon polyclonal and monoclonal human T cell proliferation. Clin Exp Immunol. 74:1988;206-210.
165. Barnes P F, Chatterjee D, Abrams J S. Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. J Immunol. 149:1992;541-547.
166. Barnes P F, Modlin R L, Ellner J J. T-cell responses and cytokines. Bloom B R. Tuberculosis: pathogenesis, prevention, and control. 1994;417-435 ASM Press, Washington.
167. Averill L, Toossi Z, Aung H, Boom W H, Ellner J J. Regulation of tumor necrosis factor alpha in monocytes stimulated by the 30-kilodalton antigen of Mycobacterium tuberculosis. Infect Immun. 63:1995;3206-3320.
168. Travis J, Potempa J, Maeda H. Are bacterial proteinases pathogenic factors. Trends Microbiol. 3:1995;405-407.
169. Harrington D J. Bacterial collagenases and collagen-degrading enzymes and their potential role in human diseases. Infect Immun. 64:1996;1885-1891.
170. Myrvik Q N, Leake E S, Wright M J. Disruption of phagosomal membranes of normal alveolar macrophages by the H37Rv strain of Mycobacterium tuberculosis. A correlate of virulence. Am Rev Respir Dis. 129:1984;322-328.
171. McDonough K A, Kress Y, Bloom B R. Pathogenesis of tuberculosis: interaction of Mycobacterium tuberculosis with macrophages. Infect Immun. 61:1993;2763-2773.
172. Goebel W, Kreft J. Cytolysins and the intracellular life of bacteria. Trends Microbiol. 5:1997;86-88.
173. Udou T. Extracellular hemolytic activity in rapidly growing mycobacteria. Can J Microbiology. 40:1994;318-321.